Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2023 2
2025 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
N-acetylcysteine as an adjunctive therapy to risperidone for treatment of irritability in autism: a randomized, double-blind, placebo-controlled clinical trial of efficacy and safety.
Nikoo M, Radnia H, Farokhnia M, Mohammadi MR, Akhondzadeh S. Nikoo M, et al. Clin Neuropharmacol. 2015 Jan-Feb;38(1):11-7. doi: 10.1097/WNF.0000000000000063. Clin Neuropharmacol. 2015. PMID: 25580916 Clinical Trial.
OBJECTIVES: According to the proposed interference of N-acetylcysteine (NAC) with pathophysiologic processes of autistic disorders (ADs), we aimed to assess the effectiveness and safety of NAC as an adjunct to risperidone in the treatment of ADs in a randomized, double-bli …
OBJECTIVES: According to the proposed interference of N-acetylcysteine (NAC) with pathophysiologic processes of autistic disorders (A …
Proton pump inhibitors and risk of hearing loss; a systematic review.
Khadivi A, Amiri F, Radnia P, Salehi-Pourmehr H, Mirzaei Bavil F, Pakkhesal S, Hamzehzadeh S, Moghaddam YJ, Naseri A. Khadivi A, et al. Naunyn Schmiedebergs Arch Pharmacol. 2025 Oct;398(10):13567-13580. doi: 10.1007/s00210-025-04241-5. Epub 2025 May 9. Naunyn Schmiedebergs Arch Pharmacol. 2025. PMID: 40343450
The initial database search yielded 661 records. Four studies (total n = 208,956 participants) proceeded to full-text review and were included in the qualitative synthesis. ...
The initial database search yielded 661 records. Four studies (total n = 208,956 participants) proceeded to full-text review and were …
The value of ovarian hyperstimulation syndrome in predicting pregnancy outcome in women with polycystic ovarian syndrome and candidate for in vitro fertilization: A case-control study.
Pilehvari S, Radnia N, Ahmadiani S, Talebi-Ghane E, Alimohammadi N, Mousaei Tokaldani Z. Pilehvari S, et al. Int J Reprod Biomed. 2023 Dec 19;21(11):921-928. doi: 10.18502/ijrm.v21i11.14655. eCollection 2023 Nov. Int J Reprod Biomed. 2023. PMID: 38292512 Free PMC article.
The women were assigned to the case group (with OHSS, n = 129) and the control group (without OHSS, n = 51). Measuring the sexual hormones was performed using the enzyme-linked immunosorbent technique. ...
The women were assigned to the case group (with OHSS, n = 129) and the control group (without OHSS, n = 51). Measuring the sex …
Evaluation of Vitamin D Serum Levels in Pregnant Women with COVID-19 Compared with the Control Group in Pregnant Women: A Case-Control Study.
Sedaghat M, Talebi-Ghane E, Goodarzi A, Kamkari S, Anvari R, Beheshti Rouy R, Radnia N. Sedaghat M, et al. SN Compr Clin Med. 2023;5(1):140. doi: 10.1007/s42399-023-01478-0. Epub 2023 May 10. SN Compr Clin Med. 2023. PMID: 37193317 Free PMC article.
The [25(OH) D] level of lower than 30 ng/ml was observed in 43.5% of the control group (n = 27) and 71.4% of the case group (n = 45; p = 0.002). Multivariate linear regression analysis to match age, gestational age, [25(OH) D] supplement use, and number of pregnanci …
The [25(OH) D] level of lower than 30 ng/ml was observed in 43.5% of the control group (n = 27) and 71.4% of the case group (n …